154 related articles for article (PubMed ID: 24673739)
1. Potent fluorinated agelastatin analogues for chronic lymphocytic leukemia: design, synthesis, and pharmacokinetic studies.
Stout EP; Choi MY; Castro JE; Molinski TF
J Med Chem; 2014 Jun; 57(12):5085-93. PubMed ID: 24673739
[TBL] [Abstract][Full Text] [Related]
2. Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe.
Jouanneau M; McClary B; Reyes JC; Chen R; Chen Y; Plunkett W; Cheng X; Milinichik AZ; Albone EF; Liu JO; Romo D
Bioorg Med Chem Lett; 2016 Apr; 26(8):2092-7. PubMed ID: 26951751
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of Agelastatin Derivatives as Potent Modulators for Cancer Invasion and Metastasis.
Antropow AH; Xu K; Buchsbaum RJ; Movassaghi M
J Org Chem; 2017 Aug; 82(15):7720-7731. PubMed ID: 28696693
[TBL] [Abstract][Full Text] [Related]
4. New total synthesis of the marine antitumor alkaloid (-)-agelastatin A.
Domostoj MM; Irving E; Scheinmann F; Hale KJ
Org Lett; 2004 Jul; 6(15):2615-8. PubMed ID: 15255704
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of all known (-)-agelastatin alkaloids.
Han S; Siegel DS; Morrison KC; Hergenrother PJ; Movassaghi M
J Org Chem; 2013 Dec; 78(23):11970-84. PubMed ID: 24152243
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis of (+/-)-agelastatin A, a potent inhibitor of osteopontin-mediated neoplastic transformations.
Dickson DP; Wardrop DJ
Org Lett; 2009 Mar; 11(6):1341-4. PubMed ID: 19228041
[TBL] [Abstract][Full Text] [Related]
7. A short total synthesis of the marine sponge pyrrole-2-aminoimidazole alkaloid (±)-agelastatin A.
Duspara PA; Batey RA
Angew Chem Int Ed Engl; 2013 Oct; 52(41):10862-6. PubMed ID: 24038621
[No Abstract] [Full Text] [Related]
8. Enantiospecific formal total synthesis of the tumor and GSK-3 beta inhibiting alkaloid, (-)-agelastatin A.
Hale KJ; Domostoj MM; Tocher DA; Irving E; Scheinmann F
Org Lett; 2003 Aug; 5(16):2927-30. PubMed ID: 12889910
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis of the beta-catenin inhibitor, (-)-agelastatin A: a second-generation approach based on radical aminobromination.
Yoshimitsu T; Ino T; Futamura N; Kamon T; Tanaka T
Org Lett; 2009 Aug; 11(15):3402-5. PubMed ID: 19588910
[TBL] [Abstract][Full Text] [Related]
10. The
D'Ambrosio M
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836663
[TBL] [Abstract][Full Text] [Related]
11. Compounds, compositions, and methods of agelastatin alkaloids: patent evaluation of WO2015042239 (A1).
Yoshimitsu T; Tun HW
Expert Opin Ther Pat; 2017 Feb; 27(2):113-119. PubMed ID: 28056571
[TBL] [Abstract][Full Text] [Related]
12. A stereodivergent strategy to both product enantiomers from the same enantiomer of a stereoinducing catalyst: agelastatin A.
Trost BM; Dong G
Chemistry; 2009 Jul; 15(28):6910-9. PubMed ID: 19533707
[TBL] [Abstract][Full Text] [Related]
13. A stereoselective synthesis of the bromopyrrole natural product (-)-agelastatin A.
Wehn PM; Du Bois J
Angew Chem Int Ed Engl; 2009; 48(21):3802-5. PubMed ID: 19378315
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of (-)-agelastatin A by [3.3] sigmatropic rearrangement of allyl cyanate.
Ichikawa Y; Yamaoka T; Nakano K; Kotsuki H
Org Lett; 2007 Aug; 9(16):2989-92. PubMed ID: 17602639
[TBL] [Abstract][Full Text] [Related]
15. Agelastatin E, agelastatin F, and benzosceptrin C from the marine sponge Agelas dendromorpha.
Tilvi S; Moriou C; Martin MT; Gallard JF; Sorres J; Patel K; Petek S; Debitus C; Ermolenko L; Al-Mourabit A
J Nat Prod; 2010 Apr; 73(4):720-3. PubMed ID: 20166736
[TBL] [Abstract][Full Text] [Related]
16. Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
Yang X; Shi Q; Yang SC; Chen CY; Yu SL; Bastow KF; Morris-Natschke SL; Wu PC; Lai CY; Wu TS; Pan SL; Teng CM; Lin JC; Yang PC; Lee KH
J Med Chem; 2011 Jul; 54(14):5097-107. PubMed ID: 21668000
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of C-ring aromatized analogues of phenanthridone alkaloids.
Lee S; Hwang S; Yu S; Jang W; Lee YM; Kim S
Arch Pharm Res; 2011 Jul; 34(7):1065-70. PubMed ID: 21811912
[TBL] [Abstract][Full Text] [Related]
18. Natural-product-like spiroketals and fused bicyclic acetals as potential therapeutic agents for B-cell chronic lymphocytic leukaemia.
Milroy LG; Zinzalla G; Loiseau F; Qian Z; Prencipe G; Pepper C; Fegan C; Ley SV
ChemMedChem; 2008 Dec; 3(12):1922-35. PubMed ID: 19025736
[TBL] [Abstract][Full Text] [Related]
19. Alkynyliodonium salts in organic synthesis. Development of a unified strategy for the syntheses of (-)-agelastatin A and (-)-agelastatin B.
Feldman KS; Saunders JC; Wrobleski ML
J Org Chem; 2002 Oct; 67(20):7096-109. PubMed ID: 12354005
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
Ikeda T; Yaegashi T; Matsuzaki T; Yamazaki R; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Oct; 21(19):5978-81. PubMed ID: 21865039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
